ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q4SCImago #18,229Hybrid

Hla

Abbreviation (ISO):HLA
•
Identifier (ISSN):2059-2302(Print)/2059-2310(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate IF (2026)
5↑ +0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Hla

WoS Q2
158122.5620182.7920192.9620204.5120218.762022820235.920244.1202552026
Annual Impact Factor Metric
Current (2026):5
Scopus SJR & RankScopus Q4
0.273
#18,229

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
110

110 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate40.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
48articles/year
27.46% Gold OA•89.83% Original Research

Aims & Scope

HLA publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, KIR, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or haematopoietic stem cell transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility.

Topics Covered (Recognized by AI)
BiologyGeneticsMedicineImmunologyChemistryBiochemistryComputational BiologyComputer ScienceEcologyInternal Medicine

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL BIOLOGY

Q2
Rank76/207
IndexSCIE
JCRSCIE2026

IMMUNOLOGY

Q2
Rank52/183
IndexSCIE
JCRSCIE2026

PATHOLOGY

Q1
Rank7/89
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q3
Rank109/207
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank101/183
IndexSCIE
JCISCIE2026

PATHOLOGY

Q3
Rank51/89
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5
Articles / Year404
Total Citations297
2025
IF4.1
Articles / Year560
Total Citations1,146
2024
IF5.9
Articles / Year496
Total Citations1,890
2023
IF8
Articles / Year384
Total Citations1,402
2022
IF8.762
Articles / Year441
Total Citations1,591

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #18,229Scopus Q4SCImago Profile
Scopus Coverage:2011, 2016-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q4
0.273

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4
Citations / Doc (2 years)
0.88

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,668 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations938
3-Year Documents1,303
Citable Documents1,014

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

GeneticsQ4
ImmunologyQ4
Immunology and AllergyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 40.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CELL BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Hla (abbr: HLA, ISSN: 2059-2302) is a peer-reviewed international scholarly journal in the field of Immunology and Microbiology, published by Wiley-Blackwell Publishing Ltd in United States. The periodical holds a Journal Impact Factor (JIF) of 5.00, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.273 (Q4), an H-index of 110.

The journal enforces rigorous peer evaluation with an annual output of approximately 48 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,668 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 440c8bbc-b267-4639-b7f3-925b27f6bab4
Database Updated: 2026-09-28